Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
As of close of business last night, ProKidney Corp’s stock clocked out at $0.71, down -4.04% from its previous closing price of $0.74. In other words, the price has decreased by -$4.04 from its previous closing price. On the day, 4.86 million shares were traded. PROK stock price reached its highest trading level at $1.18 during the session, while it also had its lowest trading level at $0.6501.
Ratios:
To gain a deeper understanding of PROK’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 10.93 and its Current Ratio is at 10.93.
On September 10, 2024, Guggenheim started tracking the stock assigning a Buy rating and target price of $6.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Apr 10 ’25 when Control Empresarial de Capital bought 1,032,218 shares for $0.61 per share. The transaction valued at 627,692 led to the insider holds 72,592,325 shares of the business.
Control Empresarial de Capital bought 1,900 shares of PROK for $1,155 on Apr 11 ’25. The Add’l Rep. Persons-see Ex.99-1 now owns 72,594,225 shares after completing the transaction at $0.61 per share. On Sep 19 ’24, another insider, Weber Darin J., who serves as the Chief Regulatory Officer of the company, sold 16,412 shares for $2.50 each. As a result, the insider received 41,030 and left with 103,480 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PROK now has a Market Capitalization of 1811827200 and an Enterprise Value of 1133518592. For the stock, the TTM Price-to-Sale (P/S) ratio is 2598.10. Its current Enterprise Value per Revenue stands at 14914.718 whereas that against EBITDA is -6.555.
Stock Price History:
The Beta on a monthly basis for PROK is 1.61, which has changed by -0.75 over the last 52 weeks, in comparison to a change of 0.07455289 over the same period for the S&P500. Over the past 52 weeks, PROK has reached a high of $4.44, while it has fallen to a 52-week low of $0.46. The 50-Day Moving Average of the stock is -36.02%, while the 200-Day Moving Average is calculated to be -59.86%.
Shares Statistics:
It appears that PROK traded 570.07K shares on average per day over the past three months and 1584210 shares per day over the past ten days. A total of 128.05M shares are outstanding, with a floating share count of 93.47M. Insiders hold about 27.84% of the company’s shares, while institutions hold 44.18% stake in the company. Shares short for PROK as of 1743379200 were 11927193 with a Short Ratio of 20.92, compared to 1740700800 on 11933117. Therefore, it implies a Short% of Shares Outstanding of 11927193 and a Short% of Float of 13.120000000000001.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
At present, 3.0 analysts are actively evaluating the performance of ProKidney Corp (PROK) in the stock market.The consensus estimate for the next quarter is -$0.16, with high estimates of -$0.14 and low estimates of -$0.17.
Analysts are recommending an EPS of between -$0.52 and -$0.72 for the fiscal current year, implying an average EPS of -$0.6. EPS for the following year is -$0.6, with 5.0 analysts recommending between -$0.46 and -$0.82.
